FYN and Alzheimer disease: Notably, it has been previously reported that Aβ promotes Fyn phosphorylation (Nygaard et al., 2014) and decreased Fyn expression prevents neuronal decline in cellular and mouse models of AD (Lambert et al., 1998), thus underlining a potential clinical relevance of Fyn in AD.